Mesenbio

Newyork, United Kingdom

Mesenbio is a preclinical biopharmaceutical business based at the University of York.

$1.8M raised

Jan 2024

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Mesenbio raised?

Mesenbio has raised $1.8M in total funding. The most recent round was Seed. The last funding was announced in January 2024.

Who are Mesenbio's investors?

Mesenbio's investors include Innovate UK, DSW Ventures, NG Bio.

Where is Mesenbio headquartered?

Mesenbio is headquartered in Newyork, United Kingdom.

What does Mesenbio do?

Mesenbio is a preclinical biopharmaceutical business based at the University of York.

What stage is Mesenbio at?

Mesenbio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 9, 2024.

MLA

"Mesenbio — Funding & Investors." VCBacked, January 9, 2024, https://www.vcbacked.co/company/mesenbio. Accessed July 2, 2026.

APA

VCBacked. (2024). Mesenbio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/mesenbio

Wikipedia (cite web)

{{cite web |title=Mesenbio — Funding & Investors |url=https://www.vcbacked.co/company/mesenbio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 9, 2024.